
Use of medical cannabis increased substantially in Denmark during 2025, while the Danish Medicines Agency reported three suspected adverse-reaction cases …
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
Danish medical cannabis use rises as regulator reports no new safety signals

